Ryman releases final terms sheet for retail bond offer

RYMAN HEALTHCARE LIMITED 1
NZX & ASX RELEASE
Ryman releases final terms sheet for retail bond
offer and exchange mechanism
11 June 2026
Further to Ryman Healthcare Limited’s (NZX: RYM) announcement earlier today, the final terms sheet
relating to its offer (Offer) of 6 year fixed rate, secured, unsubordinated bonds (Bonds) is attached.

As a result of the successful bookbuild process for the Offer, holders of Ryman’s existing quoted bonds
with ticker code ‘RYM010’ (RYM010 Bonds) that are held through a custodial account (Custodial
RYM010 Bondholders) may be able to exchange all or some of their RYM010 Bonds for an equal
number of new Bonds on the issue date for the new Bonds, 22 June 2026 (on a one-for-one basis at a
face value of NZ$1.00) (Exchange Mechanism).

The Exchange Mechanism is only available to a Custodial RYM010 Bondholder if:
(a) the Custodial RYM010 Bondholder receives an allocation of new Bonds from a participant in the
bookbuild for the Offer; and
(b) Ryman and the relevant participant (acting on the authorisation of the Custodial RYM010
Bondholder) agree to the exchange.

The Exchange Mechanism is expected to open on 11 June 2026. It is expected to close at 5:00pm on 17
June 2026, and any application must be completed and confirmed with the relevant custodian in time
to be returned to the Registrar by no later than that closing time.

Full details of the Exchange Mechanism are contained in the attached final terms sheet.

To allow for an orderly settlement and redemption process, trading in all RYM010 Bonds will be
suspended from pre-market trading on 12 June 2026 to pre-market trading on 23 June 2026 (being the
expected date of initial quotation of the Bonds).

For further details, investors can contact their usual financial adviser.

Arranger and Joint Lead Manager
ANZ Bank New Zealand Limited

Joint Lead Managers
Craigs Investment Partners Limited
Forsyth Barr Limited
Westpac Banking Corporation (ABN 33 007 457 141) (acting through its New Zealand branch)

RYMAN HEALTHCARE LIMITED 2
ENDS
Authorised by
Morgan Powell
General Counsel

About Ryman
Founded in Christchurch in 1984, Ryman Healthcare is New Zealand’s largest retirement living and aged care
provider, and the leading integrated retirement living and aged care operator in Victoria. Dual listed on the NZX
and ASX, Ryman owns and operates 47 integrated retirement villages across New Zealand and Australia,
providing homes to over 15,500 residents and employing 7,800 dedicated team members.
Ryman’s villages provide a fully integrated continuum of care, bringing together independent living, assisted
living, and aged care services within a single community. This model offers residents choice, continuity, and a
genuine home for life experience as their needs change, while giving families confidence and peace of mind.
Committed to high standards of quality and service, Ryman delivers exceptional living and care experiences
alongside long-term value for residents, families, and shareholders.

Contacts
For investor relations information
Hayden Strickett, Head of Investor Relations
hayden.strickett@rymanhealthcare.com

For media information
Sarah Greig, General Manager Corporate Affairs
and Communications
sarah.greig@rymanhealthcare.com

---

Final Terms Sheet
11 June 2026
For an issue of NZ$150 million Fixed Rate Bonds due 22 June 2032
RYMAN HEALTHCARE LIMITED

RYMAN HEALTHCARE FINAL TERMS SHEET1
This final terms sheet (Terms Sheet) is prepared in respect of the issue by Ryman Healthcare Limited (Ryman) of
NZ$150 million of fixed rate, secured, unsubordinated bonds maturing on 22 June 2032 (Bonds) under its master trust
deed dated 24 November 2020, as most recently amended on 18 March 2026 and as further amended from time
to time (the Master Trust Deed) as modified and supplemented by the supplemental trust deed dated 8 June 2026
entered into between Ryman and Public Trust as supervisor (Supervisor) (together, the Trust Documents). Unless the
context otherwise requires, capitalised terms used in this Terms Sheet have the same meaning given to them in the
Trust Documents.
Important notice
The offer of Bonds is being made in reliance upon the exclusion in clause 19 of Schedule 1 of the Financial Markets
Conduct Act 2013 (FMCA). Except for the interest rate and maturity date, the Bonds will have identical rights,
privileges, limitations and conditions as Ryman’s existing NZ$150,000,000 fixed rate, secured, unsubordinated bonds
with an interest rate of 2.55% per annum maturing on 18 December 2026, which are quoted on the NZX Debt Market
under the ticker code RYM010 (the RYM010 Bonds).
Accordingly, the Bonds are of the same class as the RYM010 Bonds for the purposes of the FMCA and the Financial
Markets Conduct Regulations 2014.
Ryman is subject to a disclosure obligation that requires it to notify certain material information to NZX Limited (NZX)
for the purpose of that information being made available to participants in the market. That information can be found
by visiting www.nzx.com/companies/RYM.
The RYM010 Bonds are the only debt securities of Ryman that are currently quoted and in the same class as the Bonds.
Investors should look to the market price of the RYM010 Bonds to find out how the market assesses the returns and
risk premium for those bonds.
As a result of the successful bookbuild process for the offer, holders of the RYM010 Bonds that
hold RYM010 Bonds through a custodial account (Custodial RYM010 Bondholders) may be able to
exchange all or some of their RYM010 Bonds for an equal number of Bonds on the Issue Date (on a
one-for-one basis at a face value of NZ$1.00). This Terms Sheet is the disclosure document for the
Exchange Mechanism.
This Exchange Mechanism will only be available to a Custodial RYM010 Bondholder if:
(i) the Custodial RYM010 Bondholder receives an allocation of Bonds from a participant in the
bookbuild for the offer; and
(ii) Ryman and the relevant participant (acting on the authorisation of the Custodial RYM010
Bondholder) have agreed to the exchange in respect of an agreed number of RYM010 Bonds
(Exchanged RYM010 Bonds).
Exchange
Mechanism
IssuerRyman Healthcare Limited (Ryman).
DescriptionFixed rate, secured, unsubordinated bonds (Bonds).
Issue AmountNZ$150 million.
Tenor and
Maturity Date
6 years maturing on 22 June 2032.
StatusThe Bonds will be issued under the Trust Documents. Principal and interest amounts in respect of
the Bonds will be direct, secured, unsubordinated obligations of Ryman and rank pari passu with
all other unsubordinated obligations of Ryman, except indebtedness preferred by law.
GuarantorsConsistent with the Guarantors for Ryman’s bank facilities, including Guarantors incorporated
in New Zealand (together with Ryman, each an NZ Guarantor) and Guarantors incorporated in
Australia (each an Australian Guarantor).
PurposeThe purpose of the offer is to provide further diversity of funding sources and tenor, and the net
proceeds of the offer (excluding the value of any RYM010 Bonds exchanged under the Exchange
Mechanism described below) will be used to repay a portion of Ryman’s existing bank debt,
refinancing of RYM010 and for general corporate purposes.

RYMAN HEALTHCARE FINAL TERMS SHEET2
The Exchange Mechanism opens on the date of this Terms Sheet, 11 June 2026. It closes at 5:00pm
on 17 June 2026, and any application must be completed and confirmed with the relevant custodian
in time to be returned to the Registrar by no later than that closing time.
Ryman will purchase the Exchanged RYM010 Bonds on the Issue Date, and will satisfy its obligation
to do so by:
(a) issuing Bonds to the relevant custodian (that maintains the custodial account on behalf of its
Custodial RYM010 Bondholder participating in the Exchange Mechanism) equal in number to the
Exchanged RYM010 Bonds purchased from the relevant custodian (on a one-for-one basis); and
(b) paying a final interest payment on the Exchanged RYM010 Bonds for the period from (and
including) the previous interest payment date for the Exchanged RYM010 Bonds to (but
excluding) the Issue Date.
No additional amounts are payable by a Custodial RYM010 Bondholder for any Bonds that are issued
under the Exchange Mechanism.
Ryman’s obligation to purchase the Exchanged RYM010 Bonds will be satisfied once it has issued the
relevant number of Bonds and paid the final interest payment referred to in paragraph (b) above.
The current average market price of the RYM010 Bonds over the 20-working day period ending on
Thursday, 4 June 2026 (calculated as the average of each day’s NZX closing price) was NZ$0.9918 per
RYM010 Bond. You may check the current market price of the RYM010 Bonds (ticker code RYM010)
on NZX’s website at www.nzx.com/companies/RYM.
Any Exchanged RYM010 Bonds purchased by Ryman under the Exchange Mechanism will be
cancelled in accordance with the Trust Documents. This will reduce the total amount of RYM010
Bonds outstanding which may impact trading of the RYM010 Bonds on the secondary market.
For the avoidance of doubt, a Custodial RYM010 Bondholder may choose to continue holding
RYM010 Bonds rather than participate in the Exchange Mechanism, and the Exchange Mechanism
does not restrict:
(a) a Custodial RYM010 Bondholder from receiving an allocation of Bonds without participating in
the Exchange Mechanism;
(b) a Custodial RYM010 Bondholder from seeking to invest in more or less Bonds than the number
of RYM010 Bonds beneficially held by the Custodial RYM010 Bondholder; or
(c) any other RYM010 Bondholder (that is not a Custodial RYM010 Bondholder) from seeking to
invest in the Bonds.
The Issue Price for each Bond that is not otherwise settled under the Exchange Mechanism must be
cash settled on the Issue Date.
Investors (including holders of RYM010 Bonds) who wish to participate in the offer and invest in the
Bonds (including under the Exchange Mechanism) should contact their financial adviser, one of the
Joint Lead Managers or another primary market participant – see the sections below titled ‘Who may
apply & how to apply’ for further information.
Important: Make sure you read carefully and understand all of the terms of this Exchange
Mechanism, including any fine print in this document or in any other documents or forms relating
to this Exchange Mechanism. Find out what your RYM010 Bonds are really worth before exchanging
them. You can find out how much your RYM010 Bonds are likely to be worth from a financial advice
provider or other entity that offers the RYM010 Bonds. You may be able to sell your RYM010 Bonds
to other buyers on the NZX Debt Market.
Exchange
Mechanism
(continued)

RYMAN HEALTHCARE FINAL TERMS SHEET3
Holders of the Bonds (Bondholders) will share the benefit of the same security package as Ryman’s
banks and any other debt funding providers who become beneficiaries under the Security Trust
Deed (Beneficiaries) on a pro rata basis. This security is held by the Security Trustee.
The security held by the Security Trustee is:
1. first ranking registered mortgages over:
(a) for any NZ Guarantor that is not an NZ Village Company (as defined below), all land and
buildings owned by that NZ Guarantor. This includes bare land and land that is under
development and not yet used for operational retirement villages;
(b) for any NZ Guarantor which owns and operates a retirement village registered under the
Retirement Villages Act 2003 (an NZ Village Company), any land and buildings owned by
that NZ Village Company which are on separate legal titles to any land allocated for Units
(but, in the case of a care centre, only if that care centre does not include Care Suites);
2. if any care centre owned by an NZ Village Company is on a separate legal title to any land
allocated for Units and includes Care Suites, a second ranking registered mortgage over the care
centre (together with the mortgages described in paragraph 1 above, the Security Trustee’s
Mortgages); and
3. general security agreements and other security agreements granted by Ryman and any
Guarantor in favour of the Security Trustee, being those defined in the definition of “General
Security Agreements” in the Security Trust Deed (General Security Agreements). These include:
(a) a general security agreement provided by the NZ Guarantors in favour of the Security
Trustee (the Security Trustee’s NZ GSA); and
(b) various security agreements granted by Australian Guarantors, (together, the Security).
Separately, each NZ Village Company provides first ranking mortgages to the Statutory Supervisor
over all land and buildings owned by that NZ Village Company containing Units and the land
on which a care centre of any NZ Village Company is located where the care centre includes
Care Suites.
All proceeds of enforcement received under the Security Trustee’s NZ GSA and/or the Security
Trustee’s Mortgages and the Statutory Supervisor’s Mortgage are applied in accordance with each
Security Sharing Deed. The Security Trust Deed also contains rules regarding the distribution of
proceeds received by the Security Trustee on enforcement of the Security (these are subject to
the security arrangements in each Security Sharing Deed).
Under each Security Sharing Deed, the Statutory Supervisor is entitled to the proceeds of
enforcement in priority to the Security Trustee to the extent that the proceeds relate to a Unit, the
land on which the Unit is located and/or land on which a care centre is located (but only where
that care centre includes any Care Suites). The remaining proceeds of enforcement will be shared
between the Beneficiaries (including the Bondholders) on a pro rata basis.
Also, for any Australian Guarantor which operates and/or owns, and has received from a Resident
an Australian Resident Loan (or part thereof) in consideration of the right to become a Resident
in, a retirement village registered under the Retirement Villages Act 1986 (Vic) (an Australian
Village Company), each Resident has the benefit of a statutory charge over the land of the relevant
Australian Village Company to secure that company’s obligation to repay the Australian Resident
Loan paid by a Resident. This charge ranks ahead of the security interest held by the Security
Trustee over the assets of the Australian Village Company.
No registered mortgages are held in respect of any Australian Guarantor. However, the Security
Trustee has an unregistered security interest in each Australian Guarantor’s land holdings under the
relevant General Security Agreements (which will rank behind the statutory charge).
Prior to 1 September 2014, NZ Village Companies granted to a Resident a Resident Mortgage over
the NZ Village Company’s reversionary interest in the land on which the Resident’s Unit is located.
The Bondholders do not have the benefit of any Resident Mortgage.
Security

RYMAN HEALTHCARE FINAL TERMS SHEET4
Ryman must ensure at all times that:
(a) Debt to Equity Covenant: the ratio of Total Liabilities of the Ryman Group (after deducting
the aggregate value of all Resident Occupancy Advances, Australian Resident Loans and
Accommodation Bonds owing or held by the Ryman Group) to Net Tangible Assets of the Ryman
Group is no greater than 1.0:1.0; and
(b) Guaranteeing Group Coverage Covenant: the Total Tangible Assets and Adjusted EBITDA of
the Guaranteeing Group for the last twelve months must represent not less than 90% of the
Total Tangible Assets and Adjusted EBITDA of the Ryman Group taken as a whole for the last
twelve months.
Under the Master Trust Deed these financial covenants are subject to change where the equivalent
covenant in the Bank Facility Agreement is changed, provided that Ryman has certified to the Bond
Supervisor that the change is more favourable to Bondholders (if it applied to Bondholders) than
the relevant financial covenant.
If there is a breach of the Debt to Equity Covenant, Ryman must, within 6 months of the date of a
6 monthly compliance report being delivered specifying that breach (or the date on which it should
have been delivered, if earlier) remedy the breach or (if not remedied within 6 months) give notice
to the Bond Supervisor within 20 Business Days after such date of its plan to remedy the breach.
If the breach is not remedied within 6 months of the date of that notice (or the date on which it
should have been delivered, if earlier), an Event of Default will occur.
Therefore, a continued breach of the Debt to Equity Covenant will be an Event of Default
approximately 13 months after that breach is disclosed to the Bond Supervisor in the 6 monthly
compliance report.
A breach of the Guaranteeing Group Coverage Covenant is an Event of Default if: (1) it is not
remedied within 30 days after Ryman or a Ryman Group member becoming aware of the breach;
and (2) the default is, or is likely to be (in the reasonable opinion of the Bond Supervisor) materially
prejudicial to Bondholders.
Bank Facility Agreement Distribution stopper
While the Bond Supervisor does not have the benefit of a distribution stopper in respect of a breach
of the Debt to Equity Covenant unless that breach becomes an Event of Default (as described
above), under the Bank Facility Agreement, Ryman is not permitted to make a distribution if the ratio
equivalent to the Debt to Equity Covenant in that agreement is breached (unless such restriction is
waived by the relevant majority of Beneficiaries in accordance with the Bank Facility Agreement).
Refer to the Master Trust Deed for more detail on covenants that will apply to the Bonds.
Financial
Covenants
Credit RatingsNeither Ryman nor the Bonds are or will be rated.
No Public PoolAll Bonds, including oversubscriptions, have been reserved for subscription by clients of the
Joint Lead Managers, primary market participants and other persons invited to participate in
the bookbuild.
Interest Rate 5.72% per annum, being the sum of the Swap Rate plus the Issue Margin.
Issue Margin1.80% per annum.
Swap RateThe mid-market swap rate for an interest rate swap of a term matching the period from the Issue
Date to the Maturity Date, as calculated by Ryman in conjunction with the Arranger, according
to market convention, with reference to Bloomberg page ‘ICNZ2’ (or any successor page) on the
Interest Rate Set Date and expressed on a quarterly basis (rounded to 2 decimal places, if necessary,
with 0.005 being rounded up).

RYMAN HEALTHCARE FINAL TERMS SHEET5
Interest
Payments
and Interest
Payment
Dates
Interest will be paid quarterly in arrear in equal amounts on 22 March, 22 June, 22 September and
22 December (or if that day is not a Business Day, the next Business Day) of each year up to and
including the Maturity Date.
The first Interest Payment Date will be 22 September 2026.
Record Date10 days before the due date for a payment or, if that day is not a Business Day, the immediately
preceding Business Day.
ISINNZRYMD0020L1.
QuotationApplication has been made to NZX for permission to quote the Bonds on the NZX Debt Market and
all requirements of NZX relating thereto that can be complied with on or before the distribution of
this Terms Sheet have been duly complied with. However, the Bonds have not yet been approved
for trading and NZX accepts no responsibility for any statement in this Terms Sheet. NZX is a
licensed market operator, and the NZX Debt Market is a licensed market under the FMCA.
NZX Ticker
Code
RYM020.
Issue PriceNZ$1.00 per Bond.
Minimum
Application
Amount
NZ$5,000 with multiples of NZ$1,000 thereafter.
Transfer
Restrictions
Bondholders are entitled to sell or transfer their Bonds at any time subject to the terms of the Trust
Documents and applicable securities laws and regulations. Ryman may decline to accept or register
a transfer of the Bonds for the reasons set out in the Trust Documents.
No transfer may be made if the transfer would result in the transferor or the transferee holding or
continuing to hold Bonds with an aggregate principal amount of less than NZ$5,000 (other than
zero) or if the transfer is not in multiples of NZ$1,000.
Early
Redemption
Neither Bondholders nor Ryman are able to redeem the Bonds before the Maturity Date. However,
Ryman may be required to repay the Bonds early if there is an Event of Default (as described in the
Master Trust Deed).
Brokerage0.40% brokerage plus 0.35% on firm allocations paid by Ryman.
Governing
Law
New Zealand.
Who May
Apply & How
to Apply
All of the Bonds, including any oversubscriptions, have been reserved for clients of the Joint Lead
Managers, institutional investors and other persons invited to participate in the bookbuild. There is
no public pool for the Bonds.
Retail investors should contact their financial adviser, one of the Joint Lead Managers or any
primary market participant for details on how they may acquire Bonds. You can find a primary
market participant by visiting https://www.nzx.com/investing/find-a-participant.
Whether in respect of oversubscriptions or generally, any allotment of Bonds will be at Ryman’s
discretion, in consultation with the Joint Lead Managers. Ryman reserves the right to refuse all or
any part of an application without giving any reason. Each investor’s financial adviser will be able
to advise them as to what arrangements will need to be put in place for the investors to trade the
Bonds including obtaining a common shareholder number (CSN), an authorisation code (FIN) and
opening an account with a primary market participant, as well as the costs and timeframes for
putting such arrangements in place.
General
Bonds may only be offered for sale or sold in conformity with all applicable laws and regulations
in New Zealand and in any jurisdiction in which they are offered, sold or delivered. Specific selling
restrictions as at the date of this Terms Sheet are set out below for Australia.
No action has been or will be taken by Ryman which would permit an offer of Bonds, or possession
or distribution of any offering material, in any country or jurisdiction where action for that purpose
is required (other than New Zealand).
Selling
Restrictions

RYMAN HEALTHCARE FINAL TERMS SHEET6
No person may purchase, offer, sell, distribute or deliver Bonds, or have in their possession, publish,
deliver or distribute to any person, any offering material or any documents in connection with the
Bonds, in any jurisdiction other than in compliance with all applicable laws and the specific selling
restrictions set out below.
By subscribing for or otherwise acquiring any Bonds, each Holder agrees to indemnify, among
others, Ryman, the Bond Supervisor and the Joint Lead Managers for any loss suffered as a result of
any breach by the Holder of these selling restrictions.
Australia
This Terms Sheet is not a prospectus, product disclosure statement or any other form of formal
‘disclosure document’ (as defined in the Corporations Act 2001 (Cth) (the Australian Corporations
Act)) and does not contain all the information which would be required in a prospectus, product
disclosure statement or other ‘disclosure document’ under the Australian Corporations Act. This
Terms Sheet has not been and will not be lodged or registered with the Australian Securities &
Investments Commission (ASIC) or the Australian Securities Exchange and Ryman is not subject to
the continuous disclosure requirements that apply in Australia.
This Terms Sheet or any other offering material relating to the Bonds may not be distributed or
published in Australia and the Bonds must not be offered for issue or sale in Australia (including to a
person in Australia) unless:
(a) the aggregate consideration payable by each offeree is at least A$500,000 (or its equivalent
in an alternative currency and, in either case, disregarding moneys lent by the offeror or its
associates) or the offer or invitation does not otherwise require disclosure to investors under
Parts 6D.2 or 7.9 of the Australian Corporations Act;
(b) the offer does not constitute an offer to a ‘retail client’ as defined for the purposes of section
761G of the Australian Corporations Act;
(c) such action complies with any applicable laws, regulations and directives in Australia; and
(d) such action does not require any document to be lodged with ASIC.
This Terms Sheet does not take into account the investment objectives, financial situation or needs
of a particular person. Prospective investors should not construe anything in this Terms Sheet as
legal, tax or other professional advice nor as financial product advice. In particular, if any financial
product advice is, in fact, held to be given by Ryman in connection with this Terms Sheet, it is
general advice only. Ryman does not hold an Australian financial services licence and is not licensed
to provide financial product advice in relation to the Bonds.
ArrangerANZ Bank New Zealand Limited (ANZ).
Joint Lead
Managers
ANZ, Craigs Investment Partners Limited, Forsyth Barr Limited and Westpac Banking Corporation
(ABN 33 007 457 141) (acting through its New Zealand branch).
Bond
Supervisor
Public Trust.
Security
Trustee
New Zealand Permanent Trustees Limited.
RegistrarMUFG Pension & Market Services (NZ) Limited.
Statutory
Supervisor
Anchorage Trustee Services Limited (from 31 July 2026, the Statutory Supervisor will be Covenant
Trustee Services Limited).
Selling
Restrictions
(continued)

RYMAN HEALTHCARE FINAL TERMS SHEET7
Important dates
Opening DateMonday, 8 June 2026
Closing DateThursday, 11:00am NZT, 11 June 2026
Interest Rate Set DateThursday, 11 June 2026
Issue DateMonday, 22 June 2026
Expected QuotationTuesday, 23 June 2026
Maturity DateTuesday, 22 June 2032
Other information
Any internet site addresses provided in the Terms Sheet are for reference only and, except as expressly stated
otherwise, the content of any such internet site is not incorporated by reference into, and does not form part of, this
Terms Sheet.
Copies of the Trust Documents are available on the website (managed by Ryman) for the offer of the Bonds at
www.rymanhealthcare.co.nz/investors/bonds.
The Arranger, the Joint Lead Managers and their respective directors, officers, employees and agents:
(a) have not authorised or caused the issue of, or made any statement in, any part of this Terms Sheet;
(b) do not make any representation, recommendation or warranty, express or implied regarding the origin, validity,
accuracy, adequacy, reasonableness or completeness of, or any errors or omissions in, any information, statement
or opinion contained in this Terms Sheet; and
(c) to the extent permitted by law, do not accept any responsibility or liability for this Terms Sheet or for any loss
arising from this Terms Sheet or its contents or otherwise arising in connection with the offer of Bonds.
This Terms Sheet does not constitute financial advice or a recommendation from the Arranger, any Joint Lead Manager
or any of their respective directors, officers, employees, agents or advisers to purchase any Bonds.
Investors should seek qualified, independent legal, financial and taxation advice before deciding to invest in the Bonds.
In particular, you should consult your tax adviser in relation to your specific circumstances. Investors will also be
personally responsible for ensuring compliance with relevant laws and regulations applicable to them (including any
required registrations).
For further information regarding Ryman, visit www.nzx.com/companies/RYM.
The dates set out in this Terms Sheet are indicative only and subject to change. Ryman reserves the right to cancel the
offer and the issue of the Bonds, in which case all application monies received will be refunded (without interest) as
soon as practicable.

RYMAN HEALTHCARE FINAL TERMS SHEET8
Address details
Issuer
Ryman Healthcare Limited, Airport Business Park, 92d Russley Road, P.O. Box 771, Christchurch 8140
Arranger and Joint Lead Manager
ANZ Bank New Zealand Limited, Level 26, ANZ Centre, 23 Albert Street, Auckland 1010
Joint Lead Managers
Craigs Investment Partners Limited, Level 36, Vero Centre, 48 Shortland Street, Auckland 1010
Forsyth Barr Limited, Level 22, NTT Tower, 157 Lambton Quay, Wellington 6011
Westpac Banking Corporation (ABN 33 007 457 141) (acting through its New Zealand branch)
Westpac on Takutai Square, Level 8, 16 Takutai Square, Auckland 1010
Supervisor
Public Trust, Level 16, SAP Tower, 151 Queen Street, Auckland 1010
Security Trustee
New Zealand Permanent Trustees Limited, Level 16, SAP Tower, 151 Queen Street, Auckland 1010
Registrar
MUFG Pension & Market Services (NZ) Limited, Level 30, PwC Tower, 15 Customs Street West, Auckland 1010
P.O. Box 91976, Auckland 1142
+64 9 375 5998
Legal Advisers to Ryman
Chapman Tripp, Level 34, PwC Tower, 15 Customs Street West, Auckland 1010